Custom Orthotics for Plantar Fasciitis: A Clinical Guide

Clinical overview for practitioners and patients · Updated July 18, 2026

Plantar fasciitis affects roughly 1 in 10 adults during their lifetime and is the most common cause of inferior heel pain seen in podiatric, orthopedic, and sports-medicine practice. Custom orthotics are one of the most studied conservative interventions — but they are also one of the most misunderstood. This guide summarizes what the evidence says, when a custom device beats an over-the-counter (OTC) insert, and how to prescribe one that actually works.

What is plantar fasciitis?

Plantar fasciitis is a degenerative enthesopathy of the plantar aponeurosis at its medial calcaneal tuberosity origin. Despite the "-itis" suffix, histology shows fasciosis — collagen disorganization, angiofibroblastic hyperplasia, and microtears — rather than acute inflammation. Contributing factors include:

• Excessive pronation or a rigid cavus foot with poor shock attenuation
• Reduced ankle dorsiflexion (positive Silfverskiöld test / gastroc equinus)
• Obesity (BMI > 27 is an independent risk factor)
• Prolonged standing or sudden increases in activity load
• Leg-length discrepancy > 10 mm

Custom vs OTC: what the evidence actually shows

Systematic reviews (Whittaker 2018, Rasenberg 2018, Cochrane 2021) converge on a few practical conclusions:

• Short term (0–6 weeks): prefabricated and custom orthoses reduce pain comparably. If cost or access is a barrier, a well-fitted OTC device with a deep heel cup and medial arch is a reasonable first step.
• Medium term (7–12 weeks): custom foot orthoses show a small but consistent advantage in function (FFI, FAAM) — particularly in patients with marked rearfoot valgus or navicular drop > 10 mm.
• Long term (> 12 weeks): combining orthoses with a plantar-fascia and gastrocnemius stretching program outperforms either alone. Orthoses without stretching underperform.
• Recalcitrant cases: custom devices with a Kirby medial heel skive (2–4 mm) and a first-ray cut-out give the strongest supination moment across the subtalar joint and are the design of choice for high-BMI or hyperpronated patients.

When to prescribe a custom device

Consider a custom orthotic when the patient presents with:

• Symptoms persisting > 6 weeks despite OTC inserts, stretching, and load management
• Structural deformity (rigid pes cavus, severe rearfoot valgus, forefoot varus > 8°)
• Concurrent posterior tibial tendon dysfunction (PTTD stage I–II)
• Diabetes or peripheral neuropathy — offloading requires tuned pressure redistribution
• Occupational standing loads > 6 h/day
• Leg-length discrepancy requiring a lift built into the device

Prescription pearls

A custom device is only as good as the assessment behind it. Key parameters to specify on the order:

• Shell: semi-rigid polypropylene 3.5–4.5 mm for adults < 90 kg; 4.5–5.5 mm above.
• Heel cup depth: 16–18 mm to contain the calcaneal fat pad.
• Medial heel skive: 2 mm (mild), 4 mm (moderate hyperpronation), 6 mm (severe / PTTD).
• Top cover: 3 mm EVA for standard use; PPT + Poron for diabetic patients.
• Rearfoot post: 4° extrinsic varus post for pronators; avoid in rigid cavus.
• Forefoot accommodation: Morton's extension if hallux limitus coexists.

What to tell patients

Expectations drive adherence. Counsel patients that:

• Break-in is progressive — 1 hour on day one, adding an hour daily.
• Meaningful pain reduction typically appears at 4–8 weeks, not days.
• Devices must be worn in supportive, lace-up footwear with a firm heel counter — not sandals or minimalist shoes.
• Nightly plantar-fascia and calf stretching (3 × 10 reps, 30-second holds) roughly doubles the effect size.
• Weight loss of 5–10 % in overweight patients meaningfully reduces recurrence.

When custom orthotics aren't enough

If pain persists beyond 12 weeks despite a well-designed custom device, stretching, and activity modification, escalate the workup: rule out a calcaneal stress reaction (MRI), tarsal-tunnel syndrome, or S1 radiculopathy. Second-line options with evidence include extracorporeal shockwave therapy (ESWT), platelet-rich plasma injection, and, rarely, gastrocnemius recession for a true equinus contracture.

Bottom line

Custom orthotics are not a first-line intervention for every heel pain patient — but for the right patient (structural deformity, high BMI, occupational load, or failed OTC trial), a well-prescribed device combined with a stretching program is one of the most durable non-surgical treatments available.

This article is for educational purposes and does not replace individualized clinical judgment. Patients should consult a licensed practitioner for diagnosis and treatment.